Will the proposed Loblaw boycott reap any rewards?

We explore the escalating chatter over a potential boycott against Loblaws, urging for a 15% price cut. Rubina Ahmed Haq sheds light on the boycott’s rationale, evaluates its feasibility, examines its potential repercussions on Loblaws. She also looks at how Loblaws should respond to the growing consumer backlash.

• Shoppers faces proposed class action over claims company is ‘abusive’ to pharmacists